Comparative effectiveness of SGLT2 inhibitors, GLP-1 receptor agonists, DPP-4 inhibitors, and sulfonylureas on risk of major adverse cardiovascular events: emulation of a randomised target trial using electronic health records
| Autor: | Xie, Yan, Bowe, Benjamin, Xian, Hong, Loux, Travis, McGill, Janet B, Al-Aly, Ziyad * |
|---|---|
| Zdroj: | In The Lancet Diabetes & Endocrinology September 2023 11(9):644-656 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|